ESMO Breast Cancer 2023 Congress Coverage
ESMO Breast Cancer 2023 DORA Phase 2 Study: Durvalumab and Olaparib in Platinum-Treated Advanced TNBC
By
ESMO Breast Cancer 2023 Congress Coverage
FEATURING
Tira Tan
By
ESMO Breast Cancer 2023 Congress Coverage
FEATURING
Tira Tan
Comments 0
Login to view comments.
Click here to Login